- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pegfilgrastim
Total 292 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruiting
-
European Organisation for Research and Treatment...NCIC Clinical Trials Group; Nordic Lymphoma Group; Lymphoma Trials Office; Australasian... and other collaboratorsCompletedLymphomaFrance, Netherlands, Spain, Canada, Belgium, Australia, Sweden, United Kingdom, New Zealand, Hungary, Croatia, Czechia, Poland
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Rush University Medical CenterTerminatedDiffuse Large B-Cell LymphomaUnited States
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Celgene; AmgenTerminatedDiffuse Large B-cell Lymphoma (DLBCL) | Burkitt Lymphoma (BL) | Follicular Lymphoma Grade III (FL III°) | Mantle Cell Lymphoma (MCL), Blastoid Variant | Aggressive Marginal Zone Lymphoma (MZL)Germany
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Unknown
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent NeuroblastomaUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
George Albert FisherSanofi; GlaxoSmithKlineCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteUnknownDiffuse Large B-Cell Lymphoma | IPI≥2Italy
-
National Research Center for Hematology, RussiaRecruitingPrimary Mediastinal LymphomaRussian Federation
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ortho Biotech, Inc.Completed
-
Michaela LiedtkeCelgene CorporationCompletedMultiple MyelomaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Completed
-
University College, LondonCancer Research UK; Cancer Research UK & UCL Cancer Trials CentreCompleted
-
University of NebraskaNational Cancer Institute (NCI)CompletedLymphoma | NeutropeniaUnited States
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsBrazil, Canada, United States, United Kingdom, Taiwan, Australia, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Russian Federation, Singapore, Spain, Sweden, Turkey
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Cancer | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder Cancer | Localized Transitional Cell Cancer... and other conditions
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer | Solid Tumor | Non-small Cell Lung Cancer
-
Cancer Research UKUnknown
-
St. Jude Children's Research HospitalRecruitingMedulloblastomaUnited States
-
Columbia UniversityCompletedBreast Cancer | Locally Advanced Malignant NeoplasmUnited States
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7United States, Canada, Japan
-
Organon and CoCompleted
-
Case Comprehensive Cancer CenterCompletedStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Stage I Adult Diffuse Large Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
University of California, San FranciscoWashington University School of Medicine; Eisai Inc.TerminatedPeripheral T-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome NegativeUnited States
-
National Cancer Institute (NCI)NRG OncologyTerminatedRecurrent Uterine Corpus Sarcoma | Uterine Corpus Leiomyosarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine SarcomaUnited States
-
St. Jude Children's Research HospitalActive, not recruiting
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast CancerUnited States
-
M.D. Anderson Cancer CenterSpectrum Pharmaceuticals, IncCompleted
-
M.D. Anderson Cancer CenterCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States